Literature DB >> 16767473

[Functional dyspepsia - diagnosis of desperation?].

T Liebregts1, B Adam, G Holtmann.   

Abstract

Dyspepsia comprises a broad spectrum of predominantly upper abdominal symptoms, such as pain, indigestion, nausea, early satiety and bloating. While these symptoms are highly prevalent, in less than 50% of patients presenting with dyspepsia, structural lesions or biochemical abnormalities are found that explain the symptoms when routine clinical tests are used. In patients without structural lesions the diagnosis of functional dyspepsia is justified. Exclusion of life-threatening disorders as the cause of symptoms and reassurance of the patient as well as proper explanation of the diagnosis and its underlying disease mechanisms (i.e. symptoms are due to a sensitive gut) is crucial and can be considered as an essential element of treatment. Since there is a remarkable comorbidity of anxiety and depression, psychosomatic interventions might be necessary in selected patients. Based on controlled clinical trials few drugs, such as proton pump inhibitors, prokinetics, tricyclic antidepressants, simethicone and selected herbal preparations have been found to be effective for treatment of functional dyspepsia. Effects of H. pylori eradication, even though strongly advocated, are most likely due to undiagnosed peptic ulcer disease in a very small group of patients. While there is currently no therapy that cures functional dyspepsia, the therapeutic target is to control symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16767473     DOI: 10.1007/s00108-006-1624-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  40 in total

Review 1.  Effects of a fixed combination of peppermint oil and caraway oil on symptoms and quality of life in patients suffering from functional dyspepsia.

Authors:  Gerald Holtmann; S Haag; B Adam; Petra Funk; Veronika Wieland; Claus-Jürgen Heydenreich
Journal:  Phytomedicine       Date:  2003       Impact factor: 5.340

2.  Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

Authors:  K McColl; L Murray; E El-Omar; A Dickson; A El-Nujumi; A Wirz; A Kelman; C Penny; R Knill-Jones; T Hilditch
Journal:  N Engl J Med       Date:  1998-12-24       Impact factor: 91.245

3.  Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

Authors:  P Moayyedi; R Feltbower; J Brown; S Mason; J Mason; J Nathan; I D Richards; A C Dowell; A T Axon
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

4.  Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicentre study.

Authors:  T Hausken; G Stene-Larsen; O Lange; O Aronsen; T Nerdrum; F Hegbom; T Schulz; A Berstad
Journal:  Scand J Gastroenterol       Date:  1990-10       Impact factor: 2.423

5.  Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia.

Authors:  B May; H D Kuntz; M Kieser; S Köhler
Journal:  Arzneimittelforschung       Date:  1996-12

6.  Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia.

Authors:  N P Breslin; A B Thomson; R J Bailey; P K Blustein; J Meddings; E Lalor; G M VanRosendaal; M J Verhoef; L R Sutherland
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

7.  Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial.

Authors:  G Holtmann; B Adam; S Haag; W Collet; E Grünewald; T Windeck
Journal:  Aliment Pharmacol Ther       Date:  2003-12       Impact factor: 8.171

8.  A placebo-controlled trial of itopride in functional dyspepsia.

Authors:  Gerald Holtmann; Nicholas J Talley; Tobias Liebregts; Birgit Adam; Christopher Parow
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

9.  Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study.

Authors:  H Gudjónsson; E Oddsson; S Björnsson; O Gunnlaugsson; A Theodors; T A Jónasson; O Bonnevie; B Thjodleifsson
Journal:  Scand J Gastroenterol       Date:  1993-11       Impact factor: 2.423

10.  Misoprostol for the treatment of chronic erosive gastritis: a double-blind placebo-controlled trial.

Authors:  P Pazzi; S Gamberini; R Scagliarini; M Dalla Libera; A Merighi; S Gullini
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.